Skip to main content
. Author manuscript; available in PMC: 2014 May 2.
Published in final edited form as: Cochrane Database Syst Rev. 2010 Jan 20;(1):CD007482. doi: 10.1002/14651858.CD007482.pub2
Methods RCT; 3 parallel groups.
Unit of randomization: individual.

Participants Dates of data collection: March-August 1991.
Setting: Ipoh, Malaysia.
Inclusion criteria: women undergoing CS.
Exclusions: hypersensitivity to 1 of antibiotics; presence of infection or fever; on antibiotics; multiple pregnancy

Interventions Cefoperazone 1g every 12 hours × 3 (N = 71) vs ampicillin 500mg every 6 hours × 4 (N = 74) at induction of anesthesia vs no treatment (N = 77); both treatment groups combined for data analysis

Outcomes Wound infection (inflammation over wound with serous or purulent discharge); any antibiotics post-operatively (cefoperazone vs ampicillinvs no treatment: 6.6% vs 16.2% vs 25.7%). Hospital stay: ampicillin vs no treatment 5.57 days (SD 1.43) vs 6.5 days (SD 3.67)

Notes Author’s definition of emergency not consistent with criteria used in this review; classified as both/undefined
Class of antibiotic: third generation cephalosporin or aminopenicillin (ampicillin)
Subgroups:
  • type of CS unclear;

  • before cord clamping.


Risk of bias

Item Authors’ judgement Description

Adequate sequence generation? Unclear “… randomized…”

Allocation concealment? Unclear No information provided.

Blinding? Unclear No information provided.
All outcomes

Incomplete outcome data addressed? Unclear 2 patients excluded (1 from cefoperazone group, 1 from no treatment group); on treatment analysis performed
All outcomes

Free of selective reporting? Unclear Insufficient information to judge.

Free of other bias? Unclear The 3 groups were comparable regarding age, race, parity, gestational age, etc. But insufficient information overall

Overall low risk of bias? Unclear Mostly unclear.
HHS Vulnerability Disclosure